(Q39585681)

13 September 2017

title

Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure (English)

1 reference

13 September 2017

0 references

randomized experiment

1 reference

1 reference

M D Murray

1

1 reference

13 September 2017

M M Deer

2

1 reference

13 September 2017

J A Ferguson

3

1 reference

13 September 2017

P R Dexter

4

1 reference

13 September 2017

S J Bennett

5

1 reference

13 September 2017

S M Perkins

6

1 reference

13 September 2017

F E Smith

7

1 reference

13 September 2017

K A Lane

8

1 reference

13 September 2017

L D Adams

9

1 reference

13 September 2017

W M Tierney

10

1 reference

13 September 2017

D C Brater

11

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

American Journal of Medicine

13 September 2017

published in

1 reference

13 September 2017

volume

111

1 reference

13 September 2017

issue

7

1 reference

13 September 2017

page(s)

513-520

1 reference

The management of chronic heart failure

13 September 2017

uses

randomized experiment

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900903-2

Hormones and hemodynamics in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900903-2

Acute and Long Term Effects of Loop Diuretics in Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900903-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900903-2

Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900903-2

Furosemide pharmacokinetics and pharmacodynamics in health and disease--an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900903-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900903-2

Benefits and risks of torasemide in congestive heart failure and essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900903-2

Determining the effectiveness of torasemide and furosemide in heart failure: design of a randomised comparison using the regenstrief medical record system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900903-2

Development and application of a population-oriented measure of ambulatory care case-mix.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900903-2

The Regenstrief Medical Record System: a quarter century experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900903-2

Effects of computer-based prescribing on pharmacist work patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900903-2

Nonparametric Estimation from Incomplete Observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900903-2

Development and testing of a new measure of health status for clinical trials in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900903-2

Measurement of health-related quality of life in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900903-2

Healthcare costs of patients with heart failure treated with torasemide or furosemide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900903-2

The effects of diuresis on the pharmacokinetics of the loop diuretics furosemide and torsemide in patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900903-2

Furosemide absorption altered in decompensated congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900903-2

Implications of intraindividual variability in bioavailability studies of furosemide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900903-2

Beliefs about medication and dietary compliance in people with heart failure: an instrument development study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900903-2

Torasemide. An update of its pharmacological properties and therapeutic efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900903-2

inferred from DOI database lookup

7 January 2021

based on heuristic

The MOS social support survey

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900903-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(01)00903-2

1 reference

release_7a4ms5uvdvh2rfp6a6eyan2ena

13 September 2017

Fatcat ID

0 references

1 reference